Exelixis, Inc.
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients…
Biotechnology
US, Alameda [HQ]
EXEL/Leadership and Strategy
Risk Factors
By Management
Not Available
No Risk Factor available yet. You can request "Risk Factors" through an email.